Literature DB >> 15544712

Nationwide survey of the role of travel medicine in primary care in Germany.

Gwendolin Ropers1, Gérard Krause, Friedrich Tiemann, Mirna Du Ry van Beest Holle, Klaus Stark.   

Abstract

BACKGROUND: With more persons traveling to (sub)tropical destinations, travel medicine is an increasing challenge for the health care system in many countries. This study investigated the role and scope of travel medicine provided by general practitioners (GPs) in primary health care, assessed the determinants of specific prophylactic recommendations, and identified the needs of GPs regarding training and cooperation in travel medicine.
METHODS: A national survey was conducted among randomly selected GPs in Germany. Information on the type and extent of activities in travel medicine, the number and characteristics of patients, the use of specific information systems, and training and cooperation, was obtained with a standardized postal questionnaire. Representativeness was assessed by a computer-assisted telephone survey among nonrespondents. Univariate and multivariate statistical analysis was performed.
RESULTS: Of all GPs (n=1,320), 95% provided medical pretravel advice or post-travel counseling (13.2 patients/month). The most common topics in pretravel consultation were immunizations (95%), malaria chemoprophylaxis (94%), advice on exposure prophylaxis (41%), and advice on protection from sexually transmitted infections (STIs) (43%). GPs frequently advised certain patient groups (e.g., cardiovascular patients 68%, pregnant women 20%). Travelers' diarrhea was the most common topic in post-travel consultation (89%), followed by fever (38%). Of the GPs, 25% cooperated regularly with institutions with special expertise in travel medicine or tropical diseases. Sixty-four percent had received some training in travel medicine, and 86% stated a need for additional training. In the multivariate analysis, independent determinants for advice on exposure prophylaxis and STI risks included special training in travel medicine, use of country-specific information sources, and location of the practice in the former West Germany and urban areas.
CONCLUSIONS: Travel medicine is of importance in primary health care in Germany. There is a need for improved counseling on exposure and STI prophylaxis. GPs' training in travel medicine and cooperation with institutions such as institutes, clinics and laboratories for tropical medicine should be improved.

Entities:  

Mesh:

Year:  2004        PMID: 15544712     DOI: 10.2310/7060.2004.19104

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  6 in total

1.  Chemoprophylaxis and malaria death rates.

Authors:  Gérard Krause; Irene Schöneberg; Doris Altmann; Klaus Stark
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

2.  Australian Pharmacists' Perceptions and Practices in Travel Health.

Authors:  Ian M Heslop; Richard Speare; Michelle Bellingan; Beverley D Glass
Journal:  Pharmacy (Basel)       Date:  2018-08-22

3.  Primary care physicians' knowledge of travel vaccine and malaria chemoprophylaxis and associated predictors in Qatar.

Authors:  Ayman Al-Dahshan; Nagah Selim; Noora Al-Kubaisi; Ziyad Mahfoud; Vahe Kehyayan
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

4.  Notifiable disease surveillance and practicing physicians.

Authors:  Gérard Krause; Gwendolin Ropers; Klaus Stark
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

5.  The Impact of Receiving Pretravel Health Advice on the Prevention of Hajj-Related Illnesses Among Australian Pilgrims: Cohort Study.

Authors:  Amani S Alqahtani; Saeed A Alsharif; Mohammad A Garnan; Mohamed Tashani; Nasser F BinDhim; Anita E Heywood; Robert Booy; Kerrie E Wiley; Harunor Rashid
Journal:  JMIR Public Health Surveill       Date:  2020-07-14

Review 6.  Prevention of Medical Events During Air Travel: A Narrative Review.

Authors:  Diane Naouri; Frederic Lapostolle; Claire Rondet; Olivier Ganansia; Dominique Pateron; Youri Yordanov
Journal:  Am J Med       Date:  2016-06-04       Impact factor: 4.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.